Abstract

Multidrug-resistant organisms (MDRO) and in particular multidrug-resistant Gram-negative organisms (MRGN) are an increasing problem in hospital care. However, data on the current prevalence of MDRO in long-term care facilities (LTCFs) are rare. To assess carriage rates of MDRO in LTCF residents in the German Rhine-Main region, we performed a point prevalence survey in 2013. Swabs from nose, throat and perineum were analysed for meticillin-resistant Staphylococcus aureus (MRSA), perianal swabs were analysed for extended-spectrum beta-lactamase (ESBL)-producing organisms, MRGN and vancomycin-resistant enterococci (VRE). In 26 LTCFs, 690 residents were enrolled for analysis of MRSA colonisation and 455 for analysis of rectal carriage of ESBL/MRGN and VRE. Prevalences for MRSA, ESBL/MRGN and VRE were 6.5%, 17.8%, and 0.4%, respectively. MRSA carriage was significantly associated with MRSA history, the presence of urinary catheters, percutaneous endoscopic gastrostomy tubes and previous antibiotic therapy, whereas ESBL/MRGN carriage was exclusively associated with urinary catheters. In conclusion, this study revealed no increase in MRSA prevalence in LTCFs since 2007. In contrast, the rate of ESBL/MRGN carriage in German LTCFs was remarkably high. In nearly all positive residents, MDRO carriage had not been known before, indicating a lack of screening efforts and/or a lack of information on hospital discharge.

Highlights

  • Multidrug-resistant organisms (MDRO) are an increasing problem in hospital care worldwide

  • The determination of the antimicrobial susceptibility profiles and classification as extended-spectrum betalactamase (ESBL)/multidrug-resistant Gram-negative organisms (MRGN), meticillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) was performed by the VITEK 2 identification system, using either VITEK N263 (Enterobacteriaceae), P586 (Enterococcus spp.) or P580 (Staphylococcus spp.) antimicrobial susceptibility testing (AST) cards according to standard laboratory procedures under strict qualitycontrolled criteria

  • Prevalence for MDRO in swab cultures exceeded the prevalence of case history for MDRO by far: MRSA 6.5% vs 0.7%, ESBL 17.8% vs 0.7%, VRE 0.4% vs 0%

Read more

Summary

Introduction

Multidrug-resistant organisms (MDRO) are an increasing problem in hospital care worldwide. An increasing trend in the occurrence of ESBL-producing Enterobacteriaceae and even CRO is found in hospitals all over Europe [1,3,28,29], a lack of knowledge on multidrug-resistant organisms (MDRO) in nursing homes has to be stated. To issue recommendations for MDRO screening of LTCFs residents, e.g. upon admission to hospital, a better knowledge of current colonisation rates and the most relevant clinical risk factors is needed. The aim of our study was to assess the current prevalence of MDRO, MRSA, ESBL/MRGN and VRE, obtained by case history and by microbiological culture of swabs from nose, throat and perineum

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call